JP2009534471A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009534471A5 JP2009534471A5 JP2009507921A JP2009507921A JP2009534471A5 JP 2009534471 A5 JP2009534471 A5 JP 2009534471A5 JP 2009507921 A JP2009507921 A JP 2009507921A JP 2009507921 A JP2009507921 A JP 2009507921A JP 2009534471 A5 JP2009534471 A5 JP 2009534471A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pyrrolidin
- cyclohexyl
- halogens
- dichloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052736 halogen Inorganic materials 0.000 claims 24
- 150000002367 halogens Chemical class 0.000 claims 24
- 239000001257 hydrogen Substances 0.000 claims 13
- 229910052739 hydrogen Inorganic materials 0.000 claims 13
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 12
- 150000001875 compounds Chemical class 0.000 claims 10
- 150000003839 salts Chemical class 0.000 claims 10
- 239000011780 sodium chloride Substances 0.000 claims 10
- 150000002431 hydrogen Chemical class 0.000 claims 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 229910052731 fluorine Inorganic materials 0.000 claims 3
- 239000011737 fluorine Substances 0.000 claims 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 3
- WEEMQMHXSFXJAH-HNNXBMFYSA-N (3R)-3-[[2,6-dichloro-4-(4-fluorophenyl)phenyl]methyl]-1-(4,4-difluorocyclohexyl)pyrrolidin-2-one Chemical compound C1=CC(F)=CC=C1C(C=C1Cl)=CC(Cl)=C1C[C@H]1C(=O)N(C2CCC(F)(F)CC2)CC1 WEEMQMHXSFXJAH-HNNXBMFYSA-N 0.000 claims 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 2
- LRGHOJRNCDCXOM-UHFFFAOYSA-N 3-[(2,6-dichloro-4-pyridin-3-ylphenyl)methyl]-1-(4-fluorocyclohexyl)pyrrolidin-2-one Chemical compound C1CC(F)CCC1N1C(=O)C(CC=2C(=CC(=CC=2Cl)C=2C=NC=CC=2)Cl)CC1 LRGHOJRNCDCXOM-UHFFFAOYSA-N 0.000 claims 2
- YYGVNQGRTRZVKZ-UHFFFAOYSA-N 3-[(4-bromo-2-chlorophenyl)methyl]-1-(4-fluorocyclohexyl)pyrrolidin-2-one Chemical compound C1CC(F)CCC1N1C(=O)C(CC=2C(=CC(Br)=CC=2)Cl)CC1 YYGVNQGRTRZVKZ-UHFFFAOYSA-N 0.000 claims 2
- 229910052801 chlorine Inorganic materials 0.000 claims 2
- 239000000460 chlorine Substances 0.000 claims 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims 2
- FONUFKXCIACMLK-JTQLQIEISA-N (3R)-3-[(2,6-dichloro-4-hydroxyphenyl)methyl]-1-(4,4-difluorocyclohexyl)pyrrolidin-2-one Chemical compound ClC1=CC(O)=CC(Cl)=C1C[C@H]1C(=O)N(C2CCC(F)(F)CC2)CC1 FONUFKXCIACMLK-JTQLQIEISA-N 0.000 claims 1
- MGMRUPQEYPNFDM-ZDUSSCGKSA-N (3R)-3-[[2,6-dichloro-4-(1-methylpyrazol-4-yl)phenyl]methyl]-1-(4,4-difluorocyclohexyl)pyrrolidin-2-one Chemical compound C1=NN(C)C=C1C(C=C1Cl)=CC(Cl)=C1C[C@H]1C(=O)N(C2CCC(F)(F)CC2)CC1 MGMRUPQEYPNFDM-ZDUSSCGKSA-N 0.000 claims 1
- CSZVSFQKOSMQNU-HNNXBMFYSA-N (3R)-3-[[2,6-dichloro-4-(4-chlorophenyl)phenyl]methyl]-1-(4,4-difluorocyclohexyl)pyrrolidin-2-one Chemical compound C1CC(F)(F)CCC1N1C(=O)[C@H](CC=2C(=CC(=CC=2Cl)C=2C=CC(Cl)=CC=2)Cl)CC1 CSZVSFQKOSMQNU-HNNXBMFYSA-N 0.000 claims 1
- MYKBUYJYIHFCRS-HNNXBMFYSA-N (3R)-3-[[2,6-dichloro-4-[4-(trifluoromethoxy)phenyl]phenyl]methyl]-1-(4,4-difluorocyclohexyl)pyrrolidin-2-one Chemical compound C1=CC(OC(F)(F)F)=CC=C1C(C=C1Cl)=CC(Cl)=C1C[C@H]1C(=O)N(C2CCC(F)(F)CC2)CC1 MYKBUYJYIHFCRS-HNNXBMFYSA-N 0.000 claims 1
- ZZULEGMXZJPGGK-UHFFFAOYSA-N 3-[(2,6-dichloro-4-pyridin-3-ylphenyl)methyl]-1-(4,4-difluorocyclohexyl)pyrrolidin-2-one Chemical compound C1CC(F)(F)CCC1N1C(=O)C(CC=2C(=CC(=CC=2Cl)C=2C=NC=CC=2)Cl)CC1 ZZULEGMXZJPGGK-UHFFFAOYSA-N 0.000 claims 1
- RXNAJNCHFJQGSO-UHFFFAOYSA-N 3-[(4-bromo-2-chlorophenyl)methyl]-1-(4,4-difluorocyclohexyl)pyrrolidin-2-one Chemical compound C1CC(F)(F)CCC1N1C(=O)C(CC=2C(=CC(Br)=CC=2)Cl)CC1 RXNAJNCHFJQGSO-UHFFFAOYSA-N 0.000 claims 1
- RBXQDAZSSWYLOX-INIZCTEOSA-N 4-[3,5-dichloro-4-[[(3R)-1-(4,4-difluorocyclohexyl)-2-oxopyrrolidin-3-yl]methyl]phenyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(C=C1Cl)=CC(Cl)=C1C[C@H]1C(=O)N(C2CCC(F)(F)CC2)CC1 RBXQDAZSSWYLOX-INIZCTEOSA-N 0.000 claims 1
- DEVYVYTWPIJPJZ-VLXSWZPNSA-N COc1cc(Cl)c(CC2CCN([C@H]3CC[C@H](F)CC3)C2=O)c(Cl)c1 Chemical compound COc1cc(Cl)c(CC2CCN([C@H]3CC[C@H](F)CC3)C2=O)c(Cl)c1 DEVYVYTWPIJPJZ-VLXSWZPNSA-N 0.000 claims 1
- ULVDCLVSKMJNLI-GBESFXJTSA-N F[C@H]1CC[C@H](CC1)N1CC[C@@H](Cc2c(Cl)cc(OCc3ccccc3)cc2Cl)C1=O Chemical compound F[C@H]1CC[C@H](CC1)N1CC[C@@H](Cc2c(Cl)cc(OCc3ccccc3)cc2Cl)C1=O ULVDCLVSKMJNLI-GBESFXJTSA-N 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 125000001188 haloalkyl group Chemical group 0.000 claims 1
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- ABMGMVVQYFPXDH-KRWDZBQOSA-N methyl 4-[3,5-dichloro-4-[[(3R)-1-(4,4-difluorocyclohexyl)-2-oxopyrrolidin-3-yl]methyl]phenyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C(C=C1Cl)=CC(Cl)=C1C[C@H]1C(=O)N(C2CCC(F)(F)CC2)CC1 ABMGMVVQYFPXDH-KRWDZBQOSA-N 0.000 claims 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000004193 piperazinyl group Chemical group 0.000 claims 1
- 125000003386 piperidinyl group Chemical group 0.000 claims 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 1
Claims (10)
- 以下の構造式で表される化合物、又はその薬理学的に許容できる塩:
R0aはハロゲンであり、
R0bは水素又はハロゲンであり、
R1は水素、ハロゲン、−O−CH3(任意に1〜3個のハロゲンで置換されてもよい)、又は−CH3(任意に1〜3個のハロゲンで置換されてもよい)であり、
R2は水素、ハロゲン、−O−CH3(任意に1〜3個のハロゲンで置換されてもよい)、又は−CH3(任意に1〜3個のハロゲンで置換されてもよい)であり、
R3は水素又はハロゲンであり、
R4は−OH、ハロゲン、−CN、−(C1−C4)アルキル(任意に1〜3個のハロゲンで置換されてもよい)、−(C1−C6)アルコキシ(任意に1〜3個のハロゲンで置換されてもよい)、−SCF3、−C(O)O(C1−C4)アルキル、−O−CH2−C(O)NH2、−(C3−C8)シクロアルキル、−O−フェニル−C(O)O−(C1−C4)アルキル、−CH2−フェニル、−NHSO2−(C1−C4)アルキル、−NHSO2−フェニル(R21)(R21)、−(C1−C4)アルキル−C(O)N(R10)(R11)、
R5は水素、ハロゲン、−OH、−CN、−(C1−C4)アルキル(任意に1〜3個のハロゲンで置換されてもよい)、−C(O)OH、−C(O)O−(C1−C4)アルキル、−C(O)−(C1−C4)アルキル、−O−(C1−C4)アルキル(任意に1〜3個のハロゲンで置換されてもよい)、−SO2−(C1−C4)アルキル、−N(R8)(R8)、−フェニル(R21)(R21)、
R6は水素、ハロゲン、−CN又は−(C1−C4)アルキル(任意に1〜3個のハロゲンで置換されてもよい)であり、
R7は水素、ハロゲン又は−(C1−C4)アルキル(任意に1〜3個のハロゲンで置換されてもよい)であり、
R8は各々独立に、水素、−(C1−C6)アルキル(任意に1〜3個のハロゲンで置換されてもよい)、−C(O)(C1−C6)アルキル(任意に1〜3個のハロゲンで置換されてもよい)、−C(O)−(C3−C8)シクロアルキル、−S(O2)−(C3−C8)シクロアルキル又は−S(O2)−(C1−C3)アルキル(任意に1〜3個のハロゲンで置換されてもよい)であり、
R9は水素又はハロゲンであり、
R10及びR11は、各々独立に、水素若しくは−(C1−C4)アルキルであるか、又はR10及びR11はそれらが結合する窒素と共にピペリジニル、ピペラジニル又はピロリジニル基を形成し、
R21は各々独立に、水素、ハロゲン又は−(C1−C3)アルキル(任意に1〜3個のハロゲンで置換されてもよい)である]。 - R0aがフッ素であり、R0bが水素である、請求項1記載の化合物、又はその薬理学的に許容できる塩。
- R0aがフッ素であり、R0bがフッ素ある、請求項1記載の化合物、又はその薬理学的に許容できる塩。
- R1が塩素であり、R2が塩素である、請求項1から3のいずれか1項記載の化合物、又はその薬理学的に許容できる塩。
- R3が水素である、請求項1から4のいずれか1項記載の化合物、又はその薬理学的に許容できる塩。
- (R)−3−(3,5−ジクロロ−4’−フルオロ−ビフェニル−4−イルメチル)−1−(4,4−ジフルオロ−シクロヘキシル)−ピロリジン−2−オンである、請求項1記載の化合物又はその薬理学的に許容できる塩。
- 以下からなる群から選択される、請求項1記載の化合物、又はその薬理学的に許容できる塩:
(R)−3−(2,6−ジクロロ−4−ヒドロキシ−ベンジル)−1−(4,4−ジフルオロ−シクロヘキシル)−ピロリジン−2−オン、
3’,5’−ジクロロ−4’−[(R)−1−(4,4−ジフルオロ−シクロヘキシル)−2−オキソ−ピロリジン−3−イルメチル]−ビフェニル−4−カルボン酸メチルエステル、
(R)−3−(3,5−ジクロロ−4’−フルオロ−ビフェニル−4−イルメチル)−1−(4,4−ジフルオロ−シクロヘキシル)−ピロリジン−2−オン、
(R)−1−(4,4−ジフルオロ−シクロヘキシル)−3−(3,5,4’−トリクロロ−ビフェニル−4−イルメチル)−ピロリジン−2−オン、
(R)−3−(3,5−ジクロロ−4’−トリフルオロメトキシ−ビフェニル−4−イルメチル)−1−(4,4−ジフルオロ−シクロヘキシル)−ピロリジン−2−オン、
(R)−3−[2,6−ジクロロ−4−(1−メチル−1H−ピラゾル−4−イル)−ベンジル]−1−(4,4−ジフルオロ−シクロヘキシル)−ピロリジン−2−オン、
3’,5’−ジクロロ−4’−[(R)−1−(4,4−ジフルオロ−シクロヘキシル)−2−オキソ−ピロリジン−3−イルメチル]−ビフェニル−4−カルボン酸、
(R)−3−(4−ベンジルオキシ−2,6−ジクロロ−ベンジル)−シス−1−(4−フルオロ−シクロヘキシル)−ピロリジン−2−オン、
3−(2,6−ジクロロ−4−メトキシベンジル)−トランス−1−(4−フルオロ−シクロヘキシル)−ピロリジン−2−オン、
3−(4−ブロモ−2−クロロ−ベンジル)−トランス−1−(4−フルオロ−シクロヘキシル)−ピロリジン−2−オン、
3−(4−ブロモ−2−クロロ−ベンジル)−シス−1−(4−フルオロ−シクロヘキシル)−ピロリジン−2−オン、
3−(2,6−ジクロロ−4−ピリジン−3−イル−ベンジル)−シス−1−(4−フルオロ−シクロヘキシル)−ピロリジン−2−オン、
3−(2,6−ジクロロ−4−ピリジン−3−イル−ベンジル)−トランス−1−(4−フルオロ−シクロヘキシル)−ピロリジン−2−オン、
3−(4−ブロモ−2−クロロ−ベンジル)−1−(4,4−ジフルオロ−シクロヘキシル)−ピロリジン−2−オン、及び
3−(2,6−ジクロロ−4−ピリジン−3−イル−ベンジル)−1−(4,4−ジフルオロ−シクロヘキシル)−ピロリジン−2−オン。 - 請求項1から8のいずれか1項記載の化合物又はその薬理学的に許容できる塩および薬理学的に許容できる担体を含む、医薬組成物。
- 薬剤の製造用の、請求項1から8のいずれか1項記載の化合物又はその薬理学的に許容できる塩。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74544206P | 2006-04-24 | 2006-04-24 | |
US60/745,442 | 2006-04-24 | ||
PCT/US2007/067253 WO2007127704A1 (en) | 2006-04-24 | 2007-04-24 | Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2009534471A JP2009534471A (ja) | 2009-09-24 |
JP2009534471A5 true JP2009534471A5 (ja) | 2010-05-13 |
JP5118692B2 JP5118692B2 (ja) | 2013-01-16 |
Family
ID=38374154
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009507921A Expired - Fee Related JP5118692B2 (ja) | 2006-04-24 | 2007-04-24 | 11−β−ヒドロキシステロイドデヒドロゲナーゼ1の阻害剤としてのシクロヘキシル置換ピロリジノン |
Country Status (17)
Country | Link |
---|---|
US (1) | US7998999B2 (ja) |
EP (1) | EP2049475B1 (ja) |
JP (1) | JP5118692B2 (ja) |
CN (1) | CN101432262B (ja) |
AT (1) | ATE543798T1 (ja) |
AU (1) | AU2007244971B2 (ja) |
BR (1) | BRPI0710468A2 (ja) |
CA (1) | CA2649111C (ja) |
CY (1) | CY1112398T1 (ja) |
DK (1) | DK2049475T3 (ja) |
EA (1) | EA016415B1 (ja) |
ES (1) | ES2378574T3 (ja) |
MX (1) | MX2008013658A (ja) |
PL (1) | PL2049475T3 (ja) |
PT (1) | PT2049475E (ja) |
SI (1) | SI2049475T1 (ja) |
WO (1) | WO2007127704A1 (ja) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007124337A1 (en) | 2006-04-21 | 2007-11-01 | Eli Lilly And Company | Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1 |
AU2007240450B2 (en) | 2006-04-21 | 2011-12-22 | Eli Lilly And Company | Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
JP5161869B2 (ja) | 2006-04-21 | 2013-03-13 | イーライ リリー アンド カンパニー | 11−β−ヒドロキシステロイドデヒドロゲナーゼ1の阻害剤としての、シクロヘキシルピラゾール−ラクタム誘導体 |
PL2029529T3 (pl) | 2006-04-24 | 2010-11-30 | Lilly Co Eli | PODSTAWIONE PIROLIDYNONY JAKO INHIBITORY DEHYDROGENAZY 11-ß-HYDROKSYSTEROIDOWEJ TYPU 1 |
PL2021336T3 (pl) * | 2006-04-24 | 2010-11-30 | Lilly Co Eli | Inhibitory dehydrogenazy 11-ß- hydroksysteroidowej typu 1 |
AU2007244863B2 (en) | 2006-04-25 | 2012-01-19 | Eli Lilly And Company | Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
PT2035379E (pt) | 2006-04-25 | 2010-07-13 | Lilly Co Eli | Inibidores da 11-beta-hidroxiesterëide desidrogenase 1 |
EP2021337B1 (en) | 2006-04-25 | 2010-01-13 | Eli Lilly And Company | Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
EA014719B1 (ru) * | 2006-04-28 | 2011-02-28 | Эли Лилли Энд Компани | Пиперидинилзамещённые пирролидиноны в качестве ингибиторов 11-бета-гидроксистероид дегидрогеназы 1 |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
EP2243479A3 (en) | 2009-04-20 | 2011-01-19 | Abbott Laboratories | Novel amide and amidine derivates and uses thereof |
US8871208B2 (en) * | 2009-12-04 | 2014-10-28 | Abbvie Inc. | 11-β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors and uses thereof |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2683705B1 (de) | 2011-03-08 | 2015-04-22 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2018014337A1 (en) * | 2016-07-22 | 2018-01-25 | Eli Lilly And Company | 3-Chloro-N- [ (1R, 3S) -3- [5- (3, 5-dimethylimidazol-4-yl) -4H-1, 2, 4-triazol-3-yl] cyclohexyl] -N-methyl-benzamide |
GB201702221D0 (en) | 2017-02-10 | 2017-03-29 | Univ Of Sussex | Compounds |
CN108299272B (zh) * | 2018-01-31 | 2019-10-18 | 福州大学 | 一种合成1-氯-2,2,2-三氟亚乙基取代咯酮化合物的方法 |
GB201803340D0 (en) | 2018-03-01 | 2018-04-18 | Univ Of Sussex | Compounds |
RU2741910C2 (ru) * | 2019-07-09 | 2021-01-29 | Государственное бюджетное образовательное учреждение высшего образования "Российский национальный исследовательский медицинский университет имени Н.И. Пирогова" Министерства здравоохранения Российской Федерации | Соединения, обладающие антиишемическими, антиангинальными, цитопротективными свойствами, способ их получения и их применение, способ лечения нейродегенеративного заболевания, способ лечения психического расстройства |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PH25772A (en) | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
DE3837825A1 (de) | 1988-11-08 | 1990-05-10 | Hoechst Ag | Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung |
DK0705275T3 (da) | 1993-06-21 | 1999-09-20 | Novo Nordisk As | AspB28-insulin-krystaller |
WO1995007931A1 (en) | 1993-09-17 | 1995-03-23 | Novo Nordisk A/S | Acylated insulin |
US5504188A (en) | 1994-06-16 | 1996-04-02 | Eli Lilly And Company | Preparation of stable zinc insulin analog crystals |
CA2468374C (en) | 1996-08-30 | 2010-12-21 | Novo-Nordisk A/S | Glp-1 derivatives |
SE0001899D0 (sv) * | 2000-05-22 | 2000-05-22 | Pharmacia & Upjohn Ab | New compounds |
DK1423381T3 (da) * | 2001-09-06 | 2007-05-07 | Schering Corp | 17beta-hydroxysteroid-dehydrogenase type 3-inhibitorer til behandling af androgenafhængige sygdomme |
WO2004056744A1 (en) | 2002-12-23 | 2004-07-08 | Janssen Pharmaceutica N.V. | Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors |
EP1747198B1 (en) * | 2004-05-07 | 2008-06-04 | Janssen Pharmaceutica N.V. | Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
AU2005240784C1 (en) * | 2004-05-07 | 2011-12-22 | Janssen Pharmaceutica N.V. | Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
WO2006040329A1 (en) | 2004-10-12 | 2006-04-20 | Novo Nordisk A/S | 1 ibeta- hydroxysteroid dehydrogenase type 1 active spiro compounds |
US7713979B2 (en) | 2004-10-29 | 2010-05-11 | Eli Lilly And Company | Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
ES2547724T3 (es) | 2004-11-10 | 2015-10-08 | Incyte Corporation | Compuestos de lactama y su uso como productos farmacéuticos |
DK1830841T3 (da) | 2004-12-20 | 2008-10-13 | Lilly Co Eli | Cycloalkyllactamderivater som inhibitorer af 11-beta-hydroxysteroid-dehydrogenase 1 |
ES2308601T3 (es) | 2004-12-21 | 2008-12-01 | Eli Lilly And Company | Derivados de cicloalquil-lactama como inhibidores del 11-beta-hidroxiesteroide deshidrogenasa 1'. |
US20090264650A1 (en) | 2005-03-31 | 2009-10-22 | Nobuo Cho | Prophylactic/Therapeutic Agent for Diabetes |
US7998959B2 (en) | 2006-01-12 | 2011-08-16 | Incyte Corporation | Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same |
JP5161869B2 (ja) | 2006-04-21 | 2013-03-13 | イーライ リリー アンド カンパニー | 11−β−ヒドロキシステロイドデヒドロゲナーゼ1の阻害剤としての、シクロヘキシルピラゾール−ラクタム誘導体 |
AU2007240450B2 (en) | 2006-04-21 | 2011-12-22 | Eli Lilly And Company | Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
WO2007124337A1 (en) | 2006-04-21 | 2007-11-01 | Eli Lilly And Company | Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1 |
PL2029529T3 (pl) | 2006-04-24 | 2010-11-30 | Lilly Co Eli | PODSTAWIONE PIROLIDYNONY JAKO INHIBITORY DEHYDROGENAZY 11-ß-HYDROKSYSTEROIDOWEJ TYPU 1 |
PL2021336T3 (pl) | 2006-04-24 | 2010-11-30 | Lilly Co Eli | Inhibitory dehydrogenazy 11-ß- hydroksysteroidowej typu 1 |
AU2007244863B2 (en) | 2006-04-25 | 2012-01-19 | Eli Lilly And Company | Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
PT2035379E (pt) | 2006-04-25 | 2010-07-13 | Lilly Co Eli | Inibidores da 11-beta-hidroxiesterëide desidrogenase 1 |
EP2021337B1 (en) | 2006-04-25 | 2010-01-13 | Eli Lilly And Company | Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
EA014719B1 (ru) | 2006-04-28 | 2011-02-28 | Эли Лилли Энд Компани | Пиперидинилзамещённые пирролидиноны в качестве ингибиторов 11-бета-гидроксистероид дегидрогеназы 1 |
CL2008001839A1 (es) | 2007-06-21 | 2009-01-16 | Incyte Holdings Corp | Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades. |
-
2007
- 2007-04-24 DK DK07761153.1T patent/DK2049475T3/da active
- 2007-04-24 AU AU2007244971A patent/AU2007244971B2/en not_active Ceased
- 2007-04-24 MX MX2008013658A patent/MX2008013658A/es active IP Right Grant
- 2007-04-24 ES ES07761153T patent/ES2378574T3/es active Active
- 2007-04-24 BR BRPI0710468-5A patent/BRPI0710468A2/pt not_active IP Right Cessation
- 2007-04-24 EA EA200870472A patent/EA016415B1/ru not_active IP Right Cessation
- 2007-04-24 US US12/297,877 patent/US7998999B2/en not_active Expired - Fee Related
- 2007-04-24 WO PCT/US2007/067253 patent/WO2007127704A1/en active Application Filing
- 2007-04-24 PT PT07761153T patent/PT2049475E/pt unknown
- 2007-04-24 SI SI200730873T patent/SI2049475T1/sl unknown
- 2007-04-24 AT AT07761153T patent/ATE543798T1/de active
- 2007-04-24 CA CA2649111A patent/CA2649111C/en not_active Expired - Fee Related
- 2007-04-24 EP EP07761153A patent/EP2049475B1/en not_active Not-in-force
- 2007-04-24 JP JP2009507921A patent/JP5118692B2/ja not_active Expired - Fee Related
- 2007-04-24 PL PL07761153T patent/PL2049475T3/pl unknown
- 2007-04-24 CN CN2007800148098A patent/CN101432262B/zh not_active Expired - Fee Related
-
2012
- 2012-02-24 CY CY20121100194T patent/CY1112398T1/el unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2009534471A5 (ja) | ||
JP2009534412A5 (ja) | ||
JP2009535356A5 (ja) | ||
JP2009534398A5 (ja) | ||
JP2009535362A5 (ja) | ||
JP2009534468A5 (ja) | ||
JP2012510502A5 (ja) | ||
JP2010526146A5 (ja) | ||
JP2011512412A5 (ja) | ||
JP2006508935A5 (ja) | ||
JP2008523126A5 (ja) | ||
JP2007520440A5 (ja) | ||
JP2008520605A5 (ja) | ||
JP2011527334A5 (ja) | ||
NO20072371L (no) | Kinuklidinderivater og deres anvendelse som muskarine M3-reseptorantagonister | |
JP2005527627A5 (ja) | ||
JP2010501478A5 (ja) | ||
JP2002513793A5 (ja) | ||
JP2008520662A5 (ja) | ||
JP2013506674A5 (ja) | ||
JP2010520214A5 (ja) | ||
JP2005527542A5 (ja) | ||
JP2010155827A5 (ja) | ||
JP2012514020A5 (ja) | ||
JP2012524110A5 (ja) |